NCT05633056View on ClinicalTrials.gov

An Adaptive Randomized Controlled Trial

NARecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

March 7, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2029

Conditions
Multi Drug Resistant TuberculosisHIV Infections
Interventions
BEHAVIORAL

Adherence support intevention

Compare the effects of adherence support interventions on clinical and biological endpoints using an adaptive randomized platform.

Trial Locations (1)

4001

RECRUITING

King DinuZulu Hospital, Durban

All Listed Sponsors
collaborator

Centre for the AIDS Programme of Research in South Africa

NETWORK

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Columbia University

OTHER